Related Experiment Video
Updated: Sep 4, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Mycophenolic Acid Induces the Intestinal Epithelial Barrier Damage through Mitochondrial ROS
Yiyun Deng1,2, Zhe Zhang1,2, Hui Yang2
1The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Abstract:
Mycophenolic acid (MPA) may cause gastrointestinal adverse effects by damaging the intestinal epithelial barrier, the underlying mechanisms remain elusive. Studies have demonstrated that oxidative stress caused by reactive oxygen species (ROS) is linked to tight junction (TJ) proteins and apoptosis, both of which cause abnormalities in intestinal barrier function. Mitochondria, one of the main sources of ROS and abnormally high levels of ROS are linked to mitochondrial dysfunction. The aim of this study was to investigate whether MPA induces intestinal barrier dysfunction through regulation of the mitochondrial ROS. MPA-induced intestinal injury model in Kunming mice and Caco-2 cells. The effect of MPA on Caco-2 cell viability was measured by MTT; tissue diamine oxidase and endotoxin expression were determined by ELISA; expression of total proteins of ZO-1, occludin, Bax, Bcl-2, and mitochondrial proteins of Cytochrome C and Bax was measured by Western blot; and the localization of Cytochrome C with MitoTraker was observed by immunofluorescence staining. Caco-2 cell apoptosis, ROS levels, and mitochondrial membrane potential were detected by flow cytometry, while intramitochondrial ROS levels were observed by MitoSOX fluorescence staining. The results showed that MPA increased intracellular and mitochondrial ROS production to promote oxidative stress and the antioxidant NAC effectively restored ZO-1 and occludin expressions, reduced apoptosis in intestinal epithelial cells. Furthermore, we found that low concentrations of MPA caused mitochondrial damage, induced hyperpolarization of the mitochondrial membrane potential and the translocation of Cytochrome C and Bax proteins from the cytoplasm to the mitochondria. The mitochondrial protectant SS-31 reduces intracellular and intramitochondrial ROS, upregulates TJ, and reduces apoptosis. Our studies suggest that MPA-induced intestinal barrier dysfunction in vivo and in vitro is mediated, at least in part, by impairing mitochondrial function and promoting oxidative stress.
Insights
Mycophenolic acid (MPA) damages the intestinal barrier by increasing oxidative stress and mitochondrial dysfunction. Antioxidants and mitochondrial protectants can mitigate these effects, suggesting a new therapeutic approach for MPA-induced gastrointestinal issues.
Area of Science:
- Gastroenterology
- Cell Biology
- Toxicology
Background:
- Mycophenolic acid (MPA) is associated with gastrointestinal adverse effects.
- The mechanisms underlying MPA-induced intestinal barrier damage are not fully understood.
- Oxidative stress and mitochondrial dysfunction are implicated in intestinal barrier abnormalities.
Purpose of the Study:
- To investigate if MPA induces intestinal barrier dysfunction via mitochondrial reactive oxygen species (ROS).
- To explore the role of mitochondrial ROS in MPA-induced intestinal injury.
Main Methods:
- MPA-induced intestinal injury models in Kunming mice and Caco-2 cells.
- Assessed cell viability (MTT), tissue diamine oxidase, endotoxin levels (ELISA).
- Measured protein expression (ZO-1, occludin, Bax, Bcl-2, Cytochrome C) via Western blot; analyzed ROS, apoptosis, and mitochondrial membrane potential (flow cytometry); observed ROS and Cytochrome C localization (fluorescence staining).
Main Results:
- MPA increased intracellular and mitochondrial ROS, causing oxidative stress.
- Antioxidant N-acetylcysteine (NAC) restored tight junction proteins (ZO-1, occludin) and reduced apoptosis.
- MPA induced mitochondrial damage, altered membrane potential, and promoted protein translocation; mitochondrial protectant SS-31 reversed these effects.
Conclusions:
- MPA-induced intestinal barrier dysfunction is mediated by mitochondrial dysfunction and oxidative stress.
- Targeting mitochondrial ROS offers a potential therapeutic strategy for MPA-related gastrointestinal toxicity.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Mitochondrial Membranes

